Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market dynamics of Dural Arteriovenous Fistulas (DAVF) Treatment Market comes as an outcome of various factors that are attributable to the rarity of this vascular abnormality and changing healthcare landscape. This is mainly driven by increasing awareness and understanding of dural arteriovenous fistulas, unusual connections between veins and arteries in the dura mater surrounding the brain. As health professionals and the society at large become more enlightened about DAVFs, there is demand for treatment methods that can prevent occurrence of neurological complications related to these abnormalities thus making it influence market dynamics.
Technological advancements in diagnostic imaging and interventional procedures play a crucial role in shaping the market dynamics of DAVF treatment. Continuous innovation in imaging modalities like angiography, and magnetic resonance imaging (MRI), among others enhances accuracy of diagnosis thereby enabling planning for treatment. To patients with this type of congenital defect, different processes such as endovascular embolization or stereotactic radiosurgery are more preferred because they provide minimal invasion to the body system thereby contributing towards greater advancement within DAVF treatment industry.
Market competition and key players have significant effects on the dynamic nature of DAVF treatment market. The presence of radiologists who perform interventions such as neurosurgeons that treat disease conditions such as those mentioned above together with medical device manufacturers makes one realize their importance when it comes to innovation in this industry or even access to care by people affected by these diseases. Henceforth, a variety including techniques applied during intervention or range choice among different tools contributes towards a moving marketplace that ranges from patient oriented solutions for DAVFs.
Geographic factors and demographics also contribute to the market dynamics of DAVF treatment. Some regions might have more than others while age groups, gender variations across population influences what would be required in any particular area with regard to prevalence rates associated with certain diseases types 2 diabetes mellitus including forms cancerous tumors mainly form due genetic make up among other factors such as age. Various players should study the prevalence of diseases in different regions and understand their demographics so that they can design products to meet the needs of populations affected by DAVFs.
Patient awareness and education initiatives play a crucial role in driving the demand for DAVF treatment. This means that as people get to know more about DAVFs, there will be more diagnosis made hence treatment requirement increasing. By creating awareness of symptoms, risk factors and treatments available, educational programs contribute to an active approach towards DAVF management thereby fostering informed decision-making in healthcare settings.
Dural Arteriovenous Fistulas Treatment Market Highlights:
Dural Arteriovenous Fistulas Treatment Market Scenario
The dural arteriovenous fistulas treatment market is expected to grow at a CAGR of 6.60% during the forecast period 2022-2030.Dural arteriovenous fistulas (DAVF) is caused by abnormal connections between arteries and veins in a protective membrane on the outer layer of the brain and spine; it is a rare disease. These abnormal blood vessels divert blood from the normal paths. If the volume of diverted blood flow is large, tissue downstream may not receive an adequate blood and oxygen supply. The symptoms vary, depending on the location of fistulae. Headaches are among the most common symptoms with all types of DAVFs. Other symptoms include visual problems, ringing in ears, heart strokes, and others.
Increasing prevalence of brain injury and neurological disorders, increasing investment in biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the dural arteriovenous fistulas treatment market. Moreover, favorable reimbursement policies, increased applications, and significant investments in the development of advance technologies for the treatment methods likely to fuel the dural arteriovenous fistulas treatment market growth during the forecast period 2017-2023.
As per the Centers for Disease Control and Prevention in 2014, about 2.8 million TBI-related Emergency Department (ED) visits, hospitalizations, and deaths occurred in the United States. TBI (traumatic brain injury) contributed to the deaths of nearly 50,000 people. It was diagnosed in over 282,000 hospitalized cases and over 2.5 million ED visits. These consisted of TBI alone or TBI in combination with other injuries. Adults aged over 75 years have the highest rates of TBI-related hospitalization and deaths.
According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high income economies. This is far higher as compared to the number of gastrointestinal disorders, or cancers, and is expected to increase further over the coming years.
However, higher cost of these treatment procedure may hamper the dural arteriovenous fistulas treatment market growth during the corresponding period.
Intended Audience
- Pharmaceutical Companies
- Research and Development (R&D) Companies
- Government Research Institute
- Academic Institutes and Universities
Figure: Global Dural Arteriovenous Fistulae Treatment Market, by Region Market Share, 2016 (%)
Sources: Annual reports, Press release, White paper, Company presentation
Segmentations
The dural arteriovenous fistulae treatment market is segmented on the basis of type, treatment, and end user.
On the basis of type, the dural arteriovenous fistulas treatment market is segmented into type I, type II, and type III.
On the basis of application, the dural arteriovenous fistulas treatment market is segmented into surgery, stereotactic radiosurgery, embolization, and others.
On the basis of end user, the dural arteriovenous fistulas treatment market is segmented into hospitals & clinics, ambulatory surgical centers, and others.Â
Regional Analysis
The Americas dominates the dural arteriovenous fistulas treatment market owing to developing  technology, increasing cases of brain injury, rising prevalence of neurological disorders, growing healthcare spending, and increasing government support for research & development. Furthermore, increasing R&D activities and the presence of major companies have fuelled the growth of the market in this region.
Europe holds the second position in the dural arteriovenous fistulas treatment market. It is expected that the government support for research & development and availability of funds for research may drive the market in European region over the review period.
Asia Pacific is the fastest growing dural arteriovenous fistulas treatment market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing new opportunities in countries such as China, India, Japan, and South Korea projected to emerge as the fastest growing market across the globe. Furthermore, increasing demand for the neurological treatment may lead to the use of advanced equipment, which, in turn, will increase the growth of the dural arteriovenous fistulas treatment market in the region.
On the other hand, the Middle East and Africa holds the least share of the market due to limited medical facilities, lack of funds for research and development, and poor political conditions, especially, in Africa.
Key Players
Some of key the players in the dural arteriovenous fistulas treatment market are BD (U.S.), Medtronic (U.S.), B. Braun Melsungen AG (Germany), Cook (U.S.), Teleflex Incorporated (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), NxStage Medical, Inc.(U.S.), and Poly Medicure Limited.Â
Research Methodology 
Sources: Annual reports, Press release, White paper, and Company presentation
Â
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
